Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Determine if the addition of filibuvir to a standard of care (SOC) regimen of pegylated interferon alpha 2a (Pegasys) and ribavirin (Copegus) significantly increases the proportion of subjects who achieve a sustained viral response (SVR) - undetectable HCV RNA at week 72 compared to pegIFN/RBV alone.
Critère d'inclusion
- Treatment of chronic HCV genotype 1 infection